Mercer Global Advisors
APGN

Mercer Global Advisors’s Apexigen, Inc. Common Stock APGN Stock Holding History

Mercer Global Advisors’s Portfolio APGN Stock Details APGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-43,626
Closed -$19K – 2080
2023
Q2 		$19K Hold
43,626
– – ﹤0.01% 1895
2023
Q1 		$21K Hold
43,626
– – ﹤0.01% 1897
2022
Q4 		$30K Buy
+43,626
New +$85K ﹤0.01% 1892

Mercer Global Advisors's APGN Position: Q3 2023 in Review

Mercer Global Advisors sold out of Apexigen, Inc. Common Stock (APGN) in Q3 2023, closing a stake of 43,626 shares — an estimated $19K sold.

Mercer Global Advisors first reported a position in APGN in Q4 2022 and held it in 3 quarters. The position peaked at $30K in Q4 2022. 0 funds tracked by Wall St. Rank hold APGN as of Q3 2023.

  • Mercer Global Advisors reported no remaining Apexigen, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Mercer Global Advisors sold 43,626 Apexigen, Inc. Common Stock shares in Q3 2023, an estimated $19K.
  • Mercer Global Advisors first reported a position in Apexigen, Inc. Common Stock in Q4 2022 and held it in 3 quarters.
  • Mercer Global Advisors's Apexigen, Inc. Common Stock position peaked at $30K in Q4 2022.
  • 0 funds tracked by Wall St. Rank held Apexigen, Inc. Common Stock as of Q3 2023.

Based on Mercer Global Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.